The progression of left ventricular systolic and diastolic dysfunctions in hypertrophic cardiomyopathy: clinical and prognostic significance

被引:12
|
作者
Pinamonti, Bruno
Merlo, Marco [1 ]
Nangah, Rene
Korcova, Renata
Di Lenarda, Andrea
Barbati, Giulia
Sinagra, Gianfranco
机构
[1] Univ Trieste, Cardiovasc Dept, Osped Riuniti, I-34100 Trieste, Italy
关键词
hypertrophic cardiomyopathy; prognosis; restrictive filling pattern; systolic dysfunction; SUDDEN CARDIAC DEATH; DOPPLER-ECHOCARDIOGRAPHY; FILLING PRESSURES; DILATED CARDIOMYOPATHY; HEART-FAILURE; RISK-FACTORS; PATTERN; PREVALENCE; TISSUE;
D O I
10.2459/JCM.0b013e3283383355
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The significance of the progression of systolic and diastolic dysfunctions in hypertrophic cardiomyopathy (HCM) is still an open issue. We sought to evaluate the clinical and prognostic implications of the progression of left ventricular systolic and diastolic dysfunction in HCM. Methods One hundred one HCM patients were studied by echo-Doppler at baseline and during follow-up. Results During a follow-up of 109 +/- 67 months, 28% of patients showed a progression to left ventricular diastolic dysfunction, defined as restrictive filling pattern (RFP), and 16% to left ventricular systolic dysfunction (left ventricular ejection fraction < 50%). The 10-year heart transplant-free survival rate was 45% in patients with RFP at follow-up vs. 82% in the patients without RFP (P<0.001), and 52% in patients with left ventricular systolic dysfunction at follow-up vs. 75% in the patients with left ventricular ejection fraction of at least 50% (P=0.001). Baseline predictors of death/transplantation were New York Heart Association class III-IV, indexed left atrial diameter, and RFP. When RFP and left ventricular systolic dysfunction were added at follow-up, both emerged as prognostic predictors (RFP: hazard ratio 8.92, 95% confidence interval 2.5-31.86; systolic dysfunction: hazard ratio 25.35, 95% confidence interval 3.57-179.88) with a significant increase of area under the receiver-operating characteristic curves (0.81 vs. 0.70, P=0.03) with respect to the baseline model. Conclusion Left ventricular diastolic and/or systolic dysfunction at follow-up are relatively frequent in HCM and are associated with a poor prognosis. J Cardiovasc Med 11:669-677 (C) 2010 Italian Federation of Cardiology.
引用
收藏
页码:669 / 677
页数:9
相关论文
共 50 条
  • [31] Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy
    Rosmini, Stefania
    Biagini, Elena
    O'Mahony, Costantinos
    Bulluck, Heerajnarain
    Ruozi, Niccolo'
    Lopes, Luis R.
    Guttmann, Oliver
    Reant, Patricia
    Quarta, Cristina C.
    Pantazis, Antonis
    Tome-Esteban, Maria
    Mckenna, William J.
    Rapezzi, Claudio
    Elliott, Perry M.
    HEART, 2017, 103 (04) : 300 - 306
  • [32] Prognostic value of left-ventricular systolic and diastolic dyssynchrony measured from gated SPECT MPI in patients with dilated cardiomyopathy
    Wang, Cheng
    Tang, Haipeng
    Zhu, Fubao
    Jiang, Zhixin
    Shi, Jianzhou
    Zhou, Yanli
    Garcia, Ernest V.
    Li, Dianfu
    Zhou, Weihua
    JOURNAL OF NUCLEAR CARDIOLOGY, 2020, 27 (05) : 1582 - 1591
  • [33] The Prevalence and Prognostic Significance of Right Ventricular Systolic Dysfunction in Nonischemic Dilated Cardiomyopathy
    Gulati, Ankur
    Ismail, Tevfik F.
    Jabbour, Andrew
    Alpendurada, Francisco
    Guha, Kaushik
    Ismail, Nizar A.
    Raza, Sadaf
    Khwaja, Jahanzaib
    Brown, Tristan D. H.
    Morarji, Kishen
    Liodakis, Emmanouil
    Roughton, Michael
    Wage, Ricardo
    Pakrashi, Tapesh C.
    Sharma, Rakesh
    Carpenter, John-Paul
    Cook, Stuart A.
    Cowie, Martin R.
    Assomull, Ravi G.
    Pennell, Dudley J.
    Prasad, Sanjay K.
    CIRCULATION, 2013, 128 (15) : 1623 - 1633
  • [34] Left Atrial Reservoir Strain-Based Left Ventricular Diastolic Function Grading and Incident Heart Failure in Hypertrophic Cardiomyopathy
    Lee, Hyun-Jung
    Kim, Hyung-Kwan
    Rhee, Tae-Min
    Choi, You-J Ung
    Hwang, In-Chang
    Yoon, Yeonyee E.
    Park, Jun-Bean
    Lee, Seung-Pyo
    Kim, Yong-Jin
    Cho, Goo-Yeong
    CIRCULATION-CARDIOVASCULAR IMAGING, 2022, 15 (04) : 225 - 235
  • [35] Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction
    Funada, Akira
    Kanzaki, Hideaki
    Noguchi, Teruo
    Morita, Yoshiaki
    Sugano, Yasuo
    Ohara, Takahiro
    Hasegawa, Takuya
    Hashimura, Hiromi
    Ishibashi-Ueda, Hatsue
    Kitakaze, Masafumi
    Yasuda, Satoshi
    Ogawa, Hisao
    Anzai, Toshihisa
    HEART AND VESSELS, 2016, 31 (05) : 758 - 770
  • [36] Prognostic role of clinical presentation in symptomatic patients with hypertrophic cardiomyopathy
    Finocchiaro, Gherardo
    Pinamonti, Bruno
    Merlo, Marco
    Brun, Francesca
    Barbati, Giulia
    Sinagra, Gianfranco
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2012, 13 (12) : 810 - 818
  • [37] Prognostic Significance of Non-Dilated Left Ventricular Size and Mitral Regurgitation in Patients With Dilated Phase of Hypertrophic Cardiomyopathy
    Kubo, Toru
    Baba, Yuichi
    Hirota, Takayoshi
    Tanioka, Katsutoshi
    Yamasaki, Naohito
    Doi, Yoshinori L.
    Kitaoka, Hiroaki
    INTERNATIONAL HEART JOURNAL, 2017, 58 (01) : 63 - 68
  • [38] Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry
    Alaiwi, Sarah Abou
    Roston, Thomas M.
    Marstrand, Peter
    Claggett, Brian Lee
    Parikh, Victoria N.
    Helms, Adam S.
    Ingles, Jodie
    Lampert, Rachel
    Lakdawala, Neal K.
    Michels, Michelle
    Owens, Anjali T.
    Rossano, Joseph W.
    Saberi, Sara
    Abrams, Dominic J.
    Ashley, Euan A.
    Semsarian, Christopher
    Stendahl, John C.
    Ware, James S.
    Miller, Erin
    Ryan, Thomas D.
    Russell, Mark W.
    Day, Sharlene M.
    Olivotto, Iacopo
    Vissing, Christoffer R.
    Ho, Carolyn Y. Y.
    CIRCULATION, 2023, 148 (05) : 394 - 404
  • [39] Myocardial Fibrosis Attenuates the Effect of Cibenzoline on Left Ventricular Diastolic Function in Patients With Hypertrophic Cardiomyopathy
    Saito, Makoto
    Okayama, Hideki
    Yoshii, Toyofumi
    Hiasa, Go
    Sumimoto, Takumi
    Inaba, Shinji
    Nishimura, Kazuhisa
    Inoue, Katsuji
    Ogimoto, Akiyoshi
    Shigematsu, Yuji
    Funada, Jun-ichi
    Hamada, Mareomi
    Higaki, Jitsuo
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2011, 57 (02) : 207 - 212
  • [40] EFFECT OF DISOPYRAMIDE ON LEFT-VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY - COMPARISON WITH DILTIAZEM
    SUMIMOTO, T
    HAMADA, M
    OHTANI, T
    SUZUKI, M
    ABE, M
    MATSUOKA, H
    FUJIWARA, Y
    SEKIYA, M
    HIWADA, K
    CARDIOVASCULAR DRUGS AND THERAPY, 1992, 6 (04) : 425 - 428